ERBB2 and breast neoplasm: Overall, our results suggest that patients with HER2-low breast tumors often exhibit clinical features associated with a better prognosis, such as a well-differentiated phenotype and a lower proliferation index; this was particularly evident when compared to the HER2-positive group.